Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions

Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions

US Patent 11234965 · Granted Feb 1, 2022

Estimated economic value: $6,668,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-2025
Dichlorophenol HSD17B13 inhibitors and uses thereof2025
Anti-inflammatory and mydriatic intracameral solutions for inhibition of postope2024
Anti-inflammatory and mydriatic intracameral solutions for inhibition of postope2024
Stable preservative-free mydriatic and anti-inflammatory solutions for injection2024
Methods for inhibiting fibrosis in a subject in need thereof2024
Methods for inhibiting angiogenesis in a subject in need thereof2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024
Methods for treating and/or preventing graft-versus-host disease and/or diffuse 2024
Antibodies specifically binding to MASP-3 for the treatment of various diseases 2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024
Dichlorophenol HSD17B13 inhibitors and uses thereof2023